Release Date: 20/04/09 15:00 Summary: EFG Annual Report 2008 Price Sensitive: No Download Document 879.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%